Financial statements Institute Of Pharmacological Research
Balance sheet of Institute Of Pharmacological Research
Company age:
Age:
5 y. 2 m. 6 d.
Share capital:
Share capital:
5 000 PLN
Balance sheet data of INSTITUTE OF PHARMACOLOGICAL RESEARCH
|
Year
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|
| Total assets | 114 938,74 | 558 700,79 | 1 167 315,21 | 526 842,65 |
| A. Fixed assets | 0,00 | 87 193,67 | 151 236,84 | 67 758,84 |
| B. Current assets | 114 938,74 | 471 507,12 | 1 016 078,37 | 459 083,81 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 114 938,74 | 558 700,79 | 1 167 315,21 | 526 842,65 |
| A. Equity | -38 097,79 | -500 842,57 | -1 497 898,19 | -1 351 404,05 |
| B. Liabilities and provisions for liabilities | 153 036,53 | 1 059 543,36 | 2 665 213,40 | 1 878 246,70 |
| I. Long-term liabilities | 119 068,26 | 929 274,78 | 2 468 332,65 | 0,00 |
| II. Short-term liabilities | 33 968,27 | 130 268,58 | 196 880,75 | 1 878 246,70 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.